Joanne Mitchell

3.9k total citations
34 papers, 1.4k citations indexed

About

Joanne Mitchell is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Joanne Mitchell has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Joanne Mitchell's work include Platelet Disorders and Treatments (10 papers), Blood properties and coagulation (6 papers) and Hepatitis B Virus Studies (4 papers). Joanne Mitchell is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Blood properties and coagulation (6 papers) and Hepatitis B Virus Studies (4 papers). Joanne Mitchell collaborates with scholars based in United Kingdom, Australia and United States. Joanne Mitchell's co-authors include Nicola J. Mutch, Claire S. Whyte, Gael B. Morrow, Pratima Chowdary, Susan L. Hill, Robert Wilson, Graham W. Taylor, Ryoichi Amitani, Peter Cole and F Kuze and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and Biochemical Journal.

In The Last Decade

Joanne Mitchell

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne Mitchell United Kingdom 16 362 351 342 290 195 34 1.4k
Brad R. Weeks United States 27 186 0.5× 200 0.6× 513 1.5× 207 0.7× 68 0.3× 67 1.8k
M A Gougerot-Pocidalo France 19 345 1.0× 427 1.2× 407 1.2× 484 1.7× 42 0.2× 30 1.9k
Isabelle Maillet France 27 393 1.1× 607 1.7× 762 2.2× 377 1.3× 36 0.2× 47 2.6k
Muriel Pichavant France 29 170 0.5× 385 1.1× 531 1.6× 307 1.1× 38 0.2× 69 3.1k
Laurence D. Jewell Canada 19 279 0.8× 151 0.4× 839 2.5× 407 1.4× 36 0.2× 33 2.2k
Colin M. Fitzsimmons United Kingdom 23 131 0.4× 109 0.3× 185 0.5× 317 1.1× 128 0.7× 42 2.0k
James K. Roche United States 30 456 1.3× 171 0.5× 424 1.2× 392 1.4× 37 0.2× 64 2.2k
Philip J. Spagnuolo United States 22 310 0.9× 119 0.3× 205 0.6× 389 1.3× 49 0.3× 51 1.5k
Silvia M. Uriarte United States 28 112 0.3× 195 0.6× 628 1.8× 441 1.5× 31 0.2× 76 2.2k
Timur O. Yarovinsky United States 26 310 0.9× 465 1.3× 733 2.1× 541 1.9× 35 0.2× 59 2.3k

Countries citing papers authored by Joanne Mitchell

Since Specialization
Citations

This map shows the geographic impact of Joanne Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Mitchell more than expected).

Fields of papers citing papers by Joanne Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Mitchell. The network helps show where Joanne Mitchell may publish in the future.

Co-authorship network of co-authors of Joanne Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Mitchell. A scholar is included among the top collaborators of Joanne Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Mitchell. Joanne Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barclay, Murray L., et al.. (2024). The prevalence and clinical features of leflunomide‐associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohort. International Journal of Rheumatic Diseases. 27(9). e15317–e15317.
2.
Mitchell, Joanne, Helena L. Fisk, Philip C. Calder, et al.. (2024). Dietary n-3 polyunsaturated fatty acids alter the number, fatty acid profile and coagulatory activity of circulating and platelet-derived extracellular vesicles: a randomized, controlled crossover trial. American Journal of Clinical Nutrition. 119(5). 1175–1186. 6 indexed citations
3.
Mitchell, Joanne, et al.. (2024). Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis. Thrombosis Journal. 22(1). 39–39. 1 indexed citations
4.
Mitchell, Joanne, Alexander P. Bye, Renato Simões Gaspar, et al.. (2023). Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability. Research and Practice in Thrombosis and Haemostasis. 7(5). 100200–100200. 12 indexed citations
5.
Mitchell, Joanne, et al.. (2023). Interleukin-36 is vasculoprotective in both sexes despite sex-specific changes in the coronary microcirculation response to IR injury. Frontiers in Cardiovascular Medicine. 10. 1227499–1227499. 6 indexed citations
6.
Mitchell, Joanne, Neline Kriek, Amanda J. Unsworth, et al.. (2023). Multiple myeloma and its treatment contribute to increased platelet reactivity. Platelets. 34(1). 2264940–2264940. 3 indexed citations
7.
Bye, Alexander P., Willianne Hoepel, Joanne Mitchell, et al.. (2021). Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets. Blood. 138(16). 1481–1489. 67 indexed citations
8.
Whyte, Claire S., Gael B. Morrow, Joanne Mitchell, Pratima Chowdary, & Nicola J. Mutch. (2020). Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19. Journal of Thrombosis and Haemostasis. 18(7). 1548–1555. 195 indexed citations
9.
Nicoll, Amanda, Stuart K. Roberts, Joanne Mitchell, et al.. (2019). Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels. Alimentary Pharmacology & Therapeutics. 49(10). 1314–1322. 14 indexed citations
10.
Mitchell, Joanne & Nicola J. Mutch. (2018). Let's cross‐link: diverse functions of the promiscuous cellular transglutaminase factor XIII‐A. Journal of Thrombosis and Haemostasis. 17(1). 19–30. 41 indexed citations
11.
McCaughan, Geoffrey W., Stuart K. Roberts, Simone I. Strasser, et al.. (2017). Sofosbuvir and daclatasvir therapy in patients with hepatitis C‐related advanced decompensated liver disease (MELD ≥ 15). Alimentary Pharmacology & Therapeutics. 47(3). 401–411. 12 indexed citations
12.
Mitchell, Joanne, et al.. (2017). Defective α2antiplasmin cross‐linking and thrombus stability in a case of acquired factor XIII deficiency. British Journal of Haematology. 178(5). 794–799. 2 indexed citations
13.
Mitchell, Joanne, et al.. (2016). Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity. Blood. 128(24). 2834–2845. 29 indexed citations
14.
Roberts, Stuart K., Joanne Mitchell, Reynold Leung, et al.. (2013). Distribution of interferon lambda‐3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies. Journal of Gastroenterology and Hepatology. 29(1). 179–184. 5 indexed citations
15.
Dumville, Jo C, Gill Worthy, Martin Bland, et al.. (2009). Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ. 338(mar19 2). b773–b773. 175 indexed citations
16.
Gordon, Adam, D. Scott Bowden, Michael Bailey, et al.. (2006). Effects ofSilybum marianumon serum hepatitis C virus RNA, alanine aminotransferase levels and well‐being in patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology. 21(1). 275–280. 74 indexed citations
17.
Desmond, Christopher, S. Roberts, F. J. Dudley, et al.. (2005). Sustained virological response rates and durability of the response to interferon‐based therapies in hepatitis C patients treated in the clinical setting. Journal of Viral Hepatitis. 13(5). 311–315. 51 indexed citations
18.
Hill, Susan L., Joanne Mitchell, David Burnett, & R A Stockley. (1998). IgG subclasses in the serum and sputum from patients with bronchiectasis. Thorax. 53(6). 463–468. 51 indexed citations
19.
Hill, S. L., Diana Bilton, Margaret M. Johnson, et al.. (1994). Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis. Journal of Antimicrobial Chemotherapy. 33(1). 129–136. 5 indexed citations
20.
McCleskey, Ferne K., et al.. (1977). Pneumonia due to Haemophilus influenzae (H. aegyptius) biotype 3. Journal of Clinical Microbiology. 6(2). 172–173. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brad R. Weeks Breakdown of academic impact, for papers by M A Gougerot-Pocidalo Breakdown of academic impact, for papers by Isabelle Maillet Breakdown of academic impact, for papers by Muriel Pichavant Breakdown of academic impact, for papers by Laurence D. Jewell Breakdown of academic impact, for papers by Colin M. Fitzsimmons Breakdown of academic impact, for papers by James K. Roche Breakdown of academic impact, for papers by Philip J. Spagnuolo Breakdown of academic impact, for papers by Silvia M. Uriarte Breakdown of academic impact, for papers by Timur O. Yarovinsky
Rankless by CCL
2026